Boyd Peter E. 4
4 · Aquestive Therapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Boyd Peter E.
Chief People Officer
Transactions
- Purchase
Common Stock
2022-06-08$0.96/sh+2,293$2,201→ 54,532 total - Purchase
Warrant (Right to Buy)
2022-06-08$0.13/sh+2,293$298→ 2,293 totalExercise: $0.96From: 2022-12-08Exp: 2027-06-08→ Common Stock (2,293 underlying)
Footnotes (1)
- [F1]Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13